- Home
- AEE vs WST Comparison
AEE vs WST Comparison
Compare AEE & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEE
- WST
- Stock Information
- Founded
- AEE 1901
- WST 1923
- Country
- AEE United States
- WST United States
- Employees
- AEE N/A
- WST N/A
- Industry
- AEE Power Generation
- WST Medical/Dental Instruments
- Sector
- AEE Utilities
- WST Health Care
- Exchange
- AEE Nasdaq
- WST Nasdaq
- Market Cap
- AEE 25.3B
- WST 23.2B
- IPO Year
- AEE N/A
- WST N/A
- Fundamental
- Price
- AEE $91.81
- WST $322.46
- Analyst Decision
- AEE Buy
- WST Buy
- Analyst Count
- AEE 13
- WST 3
- Target Price
- AEE $86.45
- WST $460.33
- AVG Volume (30 Days)
- AEE 1.4M
- WST 519.5K
- Earning Date
- AEE 11-06-2024
- WST 10-24-2024
- Dividend Yield
- AEE 2.92%
- WST 0.26%
- EPS Growth
- AEE N/A
- WST N/A
- EPS
- AEE 4.26
- WST 6.74
- Revenue
- AEE $7,058,000,000.00
- WST $2,876,400,000.00
- Revenue This Year
- AEE $5.37
- WST N/A
- Revenue Next Year
- AEE $5.63
- WST $6.22
- P/E Ratio
- AEE $21.56
- WST $47.85
- Revenue Growth
- AEE N/A
- WST N/A
- 52 Week Low
- AEE $67.03
- WST $265.00
- 52 Week High
- AEE $95.69
- WST $413.70
- Technical
- Relative Strength Index (RSI)
- AEE 52.11
- WST 53.52
- Support Level
- AEE $91.47
- WST $313.92
- Resistance Level
- AEE $93.04
- WST $326.58
- Average True Range (ATR)
- AEE 1.27
- WST 7.66
- MACD
- AEE -0.33
- WST -0.61
- Stochastic Oscillator
- AEE 19.50
- WST 84.86
About AEE Ameren Corporation
Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas in Missouri and Illinois. It serves more than 2.4 million electricity customers and more than 900,000 natural gas customers.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, U.S., and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.